soul trial oral semaglutide cardiovascular outcomes 2024 results mace PDF) Effects of on in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized Effect of Oral Semaglutide on

To view or add a comment, sign in "The pipeline for #obesity therapies now includes 192 assets in development, with 73 oral formulations on the horizon

Common reconstitution mistakes and how to avoid them Mistakes during reconstitution compound over the entire life of the vial

Its not just about looking betterits about healthier skin overall

Long-term use is recommended for sustained benefits

Dejgaard TF, Frandsen CS, Hansen TS et al (2016) Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial